Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Main Authors: | Church, D, Midgley, R, Kerr, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
by: Midgley, R, et al.
Published: (2005) -
Cancer Biomarkers: Are We Ready for the Prime Time?
by: Alok Mishra, et al.
Published: (2010-03-01) -
The emergence of 'omics for the management of colorectal cancer.
by: Midgley, R, et al.
Published: (2011) -
Intensity-modulated radiation therapy for early-stage breast cancer: is it ready for prime time?
by: Chan TY, et al.
Published: (2017-03-01) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
by: Midgley, R, et al.
Published: (2005)